Cargando…

Activation of neuronal P2X7 receptor-Pannexin-1 mediates death of enteric neurons during colitis

Inflammatory bowel diseases (IBD) are chronic relapsing and remitting conditions associated with long-term gut dysfunction resulting from alterations to the enteric nervous system and a loss of enteric neurons(1,2). The mechanisms underlying inflammation-induced enteric neuron death are unknown. Her...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulbransen, Brian D., Bashashati, Mohammad, Hirota, Simon A., Gui, Xianyong, Roberts, Jane A., MacDonald, Justin A., Muruve, Daniel A., McKay, Derek M., Beck, Paul L., Mawe, Gary M., Thompson, Roger J., Sharkey, Keith A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321107/
https://www.ncbi.nlm.nih.gov/pubmed/22426419
http://dx.doi.org/10.1038/nm.2679
Descripción
Sumario:Inflammatory bowel diseases (IBD) are chronic relapsing and remitting conditions associated with long-term gut dysfunction resulting from alterations to the enteric nervous system and a loss of enteric neurons(1,2). The mechanisms underlying inflammation-induced enteric neuron death are unknown. Here we report using in vivo models of experimental colitis that inflammation causes enteric neuron death by activating a neuronal signaling complex comprised of P2X7 receptors (P2X7Rs), pannexin–1 (Panx1) channels, Asc and caspases. Inhibiting P2X7Rs, Panx1, Asc or caspase activity prevents inflammation-induced neuron cell death. Preservation of enteric neurons by inhibiting Panx1 in vivo prevented the onset of inflammation-induced colonic motor dysfunction. Panx1 expression is reduced in Crohn’s disease but not ulcerative colitis. We conclude that activation of neuronal Panx1 underlies neuron death and subsequent development of the abnormal gut motility in IBD. Targeting Panx1 represents a novel neuroprotective strategy to ameliorate the progression of IBD–associated dysmotility.